These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26319580)

  • 21. Neuropilins in neoplasms: expression, regulation, and function.
    Bielenberg DR; Pettaway CA; Takashima S; Klagsbrun M
    Exp Cell Res; 2006 Mar; 312(5):584-93. PubMed ID: 16445911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refuting the hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the developing kidney.
    Munro DAD; Hohenstein P; Coate TM; Davies JA
    Dev Dyn; 2017 Dec; 246(12):1047-1056. PubMed ID: 28929539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading.
    Nasarre P; Constantin B; Rouhaud L; Harnois T; Raymond G; Drabkin HA; Bourmeyster N; Roche J
    Neoplasia; 2003; 5(1):83-92. PubMed ID: 12659673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC.
    Meler-Claramonte C; Avilés-Jurado FX; Vilaseca I; Terra X; Bragado P; Fuster G; León Vintró X; Camacho M
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
    Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
    Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
    Zhang X; Klamer B; Li J; Fernandez S; Li L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.
    Bielenberg DR; Hida Y; Shimizu A; Kaipainen A; Kreuter M; Kim CC; Klagsbrun M
    J Clin Invest; 2004 Nov; 114(9):1260-71. PubMed ID: 15520858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells.
    Kusy S; Nasarre P; Chan D; Potiron V; Meyronet D; Gemmill RM; Constantin B; Drabkin HA; Roche J
    Neoplasia; 2005 May; 7(5):457-65. PubMed ID: 15967098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
    Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
    Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in expression of Class 3 Semaphorins and their receptors during development of the rat retina and superior colliculus.
    Sharma A; LeVaillant CJ; Plant GW; Harvey AR
    BMC Dev Biol; 2014 Jul; 14():34. PubMed ID: 25062604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature.
    Muley A; Odaka Y; Lewkowich IP; Vemaraju S; Yamaguchi TP; Shawber C; Dickie BH; Lang RA
    PLoS One; 2017; 12(8):e0181549. PubMed ID: 28846685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytes.
    Tang MW; Malvar Fernández B; Newsom SP; van Buul JD; Radstake TRDJ; Baeten DL; Tak PP; Reedquist KA; García S
    Rheumatology (Oxford); 2018 May; 57(5):909-920. PubMed ID: 29471421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons.
    Torigoe M; Yamauchi K; Tamada A; Matsuda I; Aiba A; Castellani V; Murakami F
    Eur J Neurosci; 2013 May; 37(10):1573-83. PubMed ID: 23534961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-128-3p directly targets VEGFC/VEGFR3 to modulate the proliferation of lymphatic endothelial cells through Ca
    Zhou J; He Z; Guo L; Zeng J; Liang P; Ren L; Zhang M; Zhang P; Huang X
    Int J Biochem Cell Biol; 2018 Sep; 102():51-58. PubMed ID: 29777777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yap1 promotes sprouting and proliferation of lymphatic progenitors downstream of Vegfc in the zebrafish trunk.
    Grimm L; Nakajima H; Chaudhury S; Bower NI; Okuda KS; Cox AG; Harvey NL; Koltowska K; Mochizuki N; Hogan BM
    Elife; 2019 Apr; 8():. PubMed ID: 31038457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonvenous origin of dermal lymphatic vasculature.
    Martinez-Corral I; Ulvmar MH; Stanczuk L; Tatin F; Kizhatil K; John SW; Alitalo K; Ortega S; Makinen T
    Circ Res; 2015 May; 116(10):1649-54. PubMed ID: 25737499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proper migration of lymphatic endothelial cells requires survival and guidance cues from arterial mural cells.
    Peng D; Ando K; Hußmann M; Gloger M; Skoczylas R; Mochizuki N; Betsholtz C; Fukuhara S; Schulte-Merker S; Lawson ND; Koltowska K
    Elife; 2022 Mar; 11():. PubMed ID: 35316177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation.
    Boscolo E; Coma S; Luks VL; Greene AK; Klagsbrun M; Warman ML; Bischoff J
    Angiogenesis; 2015 Apr; 18(2):151-62. PubMed ID: 25424831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.